Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA2 | P42262 | 2/20 | 0.51 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.51 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.51 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.51 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | XIAP | P98170 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3838965 | 1.00 | GRIA2 (0.51) | GRIA2GRIA1GRIA3GRIA4SLC7A5 | |
| SCHEMBL24834446 | 1.00 | GRIA2 (0.51) | GRIA2GRIA1GRIA3GRIA4SLC7A5 | |
| Hydrochloric Acid SCHEMBL11090438 | 0.97 | GRIA1 (0.49) | GRIA2GRIA1GRIA3GRIA4SLC7A5 | |
| Imidazole SCHEMBL8049134 | 0.88 | GRIA1 (0.46) | GRIA2GRIA1GRIA3GRIA4SLC7A5 | |
| Histidine SCHEMBL1536141 | 0.86 | GRIA1 (0.42) | GRIA2GRIA1GRIA3GRIA4SLC7A5 | |
| SCHEMBL10838551 | 0.86 | TBXAS1 (0.42) | GRIA2GRIA1GRIA3GRIA4TBXAS1 | |
| Hydrochloric Acid SCHEMBL10837657 | 0.84 | TBXAS1 (0.44) | GRIA2GRIA1GRIA3GRIA4TBXAS1 | |
| SCHEMBL3337299 | 0.84 | FDPS (0.42) | GRIA2GRIA1GRIA3GRIA4TBXAS1 | |
| SCHEMBL1176949 | 0.83 | TBXAS1 (0.51) | GRIA2GRIA1GRIA3GRIA4SLC7A5 | |
| SCHEMBL11456188 | 0.81 | TBXAS1 (0.49) | GRIA2GRIA1GRIA3GRIA4TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| EP-2124880-B1 | FLUORESCENT NANOPARTICLES | EXCHANGE IMAGING TECH GMBH (DE) | 2018-03-21 | — | — | EP | claimed |
| EP-1787659-B1 | Fluorescent nanoparticles | EXCHANGE IMAGING TECH GMBH (DE) | 2017-03-22 | — | — | EP | claimed |
| US-8974767-B2 | Fluorescent nanoparticles | SIGNALOMICS GMBH (AT) | 2015-03-10 | — | — | US | claimed |
| EP-2292837-B1 | Triazinylaminostilbene disulphonic acid mixtures | CLARIANT INT LTD (CH) | 2014-06-04 | — | — | EP | claimed |
| EP-2159044-B1 | Nanocrystals | LIFE TECHNOLOGIES CORP (US) | 2012-05-16 | — | — | EP | claimed |
| EP-1520073-B1 | TRIAZINNYLAMINOSTILBENE DISULPHONIC ACID MIXTURES | BASF SE (DE) | 2012-01-18 | — | — | EP | claimed |
| EP-2159044-A1 | Nanocrystals | Life Technologies Corporation (US) | 2010-03-03 | — | — | EP | claimed |
| EP-1456022-B1 | NANOCRYSTALS | LIFE TECHNOLOGIES CORP (US) | 2009-11-11 | — | — | EP | claimed |
| US-20090226371-A1 | FLUORESCENT NANOPARTICLES | SIGNALOMICS GMBH (AT) | 2009-09-10 | — | — | US | claimed |
| US-20020017001-A1 | Flourescent whitening agents | ROHRINGER PETER (CH) | 2002-02-14 | — | — | US | claimed |
| EP-1166179-A1 | PROCESS FOR REMOVING STAIN IN A PHOTOGRAPHIC MATERIAL | Ciba SC Holding AG (CH) | 2002-01-02 | — | — | EP | claimed |
| US-20010014989-A1 | Fluorescent whitening agents | ROHRINGER PETER (CH) | 2001-08-23 | — | — | US | claimed |
| EP-1123929-A1 | Fluorescent whitening agents | Ciba SC Holding AG (CH) | 2001-08-16 | — | — | EP | claimed |
| US-6143889-A | Asymmetric stilbene compounds | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-11-07 | — | — | US | claimed |
| US-6143888-A | TREATING THE SUBSTRATE WITH A TRIAZINE BASED ULTRAVIOLET ABSORPTION COMPOUND TO INHIBIT THE EFFECT OF AN ANIONIC FLUORECENT WHITENING AGENT | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-11-07 | — | — | US | claimed |
| WO-2000055688-A1 | PROCESS FOR REMOVING STAIN IN A PHOTOGRAPHIC MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-09-21 | — | — | WO | claimed |
| US-6084065-A | FOR AGRICULTURAL USE | ISAGRO SPA (IT) | 2000-07-04 | — | — | US | claimed |
| EP-0922699-A1 | Asymmetric stilbene compounds useful as sun protection agents | Ciba SC Holding AG (CH) | 1999-06-16 | — | — | EP | claimed |
| EP-0652229-A2 | Oligopeptides with fungicidal activity | ISAGRO S.p.A. (IT) | 1995-05-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | GRIA2 1319/4885GRIA1 1487/4885GRIA3 1691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.